Louise Cooley
Overview
Explore the profile of Louise Cooley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
335
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Coussement J, Heath C, Roberts M, Lane R, Spelman T, Smibert O, et al.
Clin Infect Dis
. 2024 Dec;
PMID: 39692570
Background: Limited data exist regarding outcomes of cryptococcosis in patients without HIV with few studies having compared outcomes of Cryptococcus gattii, versus C. neoformans, infection. Methods: We conducted a retrospective...
2.
Williams A, Coombs G, Bell J, Daley D, Mowlaboccus S, Bryant P, et al.
J Pediatric Infect Dis Soc
. 2024 Oct;
14(2).
PMID: 39468748
Background: Rising proportions of antimicrobial resistance (AMR) have been observed in both Staphylococcus aureus and Enterococcus spp. isolates. Methods: The Australian Group on Antimicrobial Resistance surveillance program captures clinical and...
3.
Williams A, Coombs G, Bell J, Daley D, Mowlaboccus S, Bryant P, et al.
J Pediatric Infect Dis Soc
. 2024 Oct;
13(12):617-625.
PMID: 39460715
Background: Gram-negative bloodstream infections are associated with significant morbidity and mortality in children. Increasing antimicrobial resistance (AMR) is reported globally, yet efforts to track pediatric AMR at a national level...
4.
Webb J, Andersson P, Sim E, Zahedi A, Donald A, Hoang T, et al.
Lancet Microbe
. 2024 Oct;
6(3):100969.
PMID: 39389079
Delivering large-scale routine pathogen genomics surveillance for public health is of considerable interest, although translational research models that promote national-level implementation are not well defined. We describe the development and...
5.
Williams A, Coombs G, Bell J, Daley D, Mowlaboccus S, Bryant P, et al.
Commun Dis Intell (2018)
. 2024 Aug;
48.
PMID: 39165021
From 1 January 2020 to 31 December 2021, thirty-eight institutions across Australia submitted data to the Australian Group on Antimicrobial Resistance (AGAR) from patients aged < 18 years (AGAR-Kids). Over...
6.
Sotheran E, Lane C, Horan K, Stevens K, Guglielmino C, Bradbury S, et al.
Open Forum Infect Dis
. 2024 Jun;
11(6):ofae249.
PMID: 38854393
Background: In Australia, invasive meningococcal disease (IMD) incidence rapidly increased between 2014 and 2017 due to rising serogroup W (MenW) and MenY infections. We aimed to better understand the genetic...
7.
Fountain-Jones N, Vanhaeften R, Williamson J, Maskell J, Chua I, Charleston M, et al.
Lancet Microbe
. 2024 Mar;
5(5):e452-e458.
PMID: 38527471
Introduction: Continued SARS-CoV-2 infection among immunocompromised individuals is likely to play a role in generating genomic diversity and the emergence of novel variants. Antiviral treatments such as molnupiravir are used...
8.
Coussement J, Heath C, Roberts M, Lane R, Spelman T, Smibert O, et al.
Clin Infect Dis
. 2023 May;
77(7):976-986.
PMID: 37235212
Background: Patients without human immunodeficiency virus (HIV) are increasingly recognized as being at risk for cryptococcosis. Knowledge of characteristics of cryptococcosis in these patients remains incomplete. Methods: We conducted a...
9.
Teh B, Reynolds G, Slavin M, Cooley L, Roberts M, Liu E, et al.
Intern Med J
. 2023 Apr;
53(8):1469-1477.
PMID: 37093163
Infection remains a significant contributor to morbidity and mortality in patients with myeloma. This guideline was developed by a multidisciplinary group of clinicians who specialise in the management of patients...
10.
Donnan E, Marais B, Coulter C, Waring J, Bastian I, Williamson D, et al.
Commun Dis Intell (2018)
. 2023 Feb;
47.
PMID: 36850064
No abstract available.